Literature DB >> 23233366

Prospective follow-up of 2,065 young unscreened women to study human papillomavirus incidence and clearance.

C E Schmeink1, L F A G Massuger, C H Lenselink, W G V Quint, B I Witte, J Berkhof, W J G Melchers, R L M Bekkers.   

Abstract

Human papillomavirus (HPV) is a necessary factor in the development of cervical intraepithelial neoplasia and cervical cancer. However, HPV is also a very common sexually transmitted virus and many women clear their infection. To study HPV incidence and clearance, 2,065 women, aged 18-29 years, were followed for 12 months and were asked to provide a self-collected cervico-vaginal sample and fill-out a questionnaire every 3 months. For HPV DNA detection, the SPF10 -DEIA LiPA25 system was used. Incidence rates of any-type high-risk HPV and low-risk HPV were 17.0 per 1,000-person months, and 14.3 per 1,000-person months, respectively. HPV types 16, 52, 51 and 31 had the highest type-specific incidence rates. HPV incidence was increased in singles, and women having a new relationship. A higher number of lifetime sex partners, and a higher frequency of sexual contacts in the past 3 months was associated with an increased HPV incidence. The overall clearance of the newly detected type-specific high-risk HPV infections and low-risk HPV infections was 61.2% and 69.0%, respectively. Having a sexual relationship compared to being single, and a higher sexual age both positively influenced the clearance of any-type high-risk HPV. Among the women infected with HPV 16, the women who had a co-infection had a lower proportion of clearance of HPV 16. In conclusion, in this young Dutch study population, HPV incidence rates are not related to age and comparable to other western countries. Clearance was only independently related to factors associated with sexual behavior, either past or current.
Copyright © 2012 UICC.

Entities:  

Mesh:

Year:  2013        PMID: 23233366     DOI: 10.1002/ijc.27986

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  17 in total

1.  Rates and determinants of incidence and clearance of cervical HPV genotypes among HIV-seropositive women in Pune, India.

Authors:  Arati Mane; Vikrant V Sahasrabuddhe; Amit Nirmalkar; Arun R Risbud; Seema Sahay; Ramesh A Bhosale; Sten H Vermund; Sanjay M Mehendale
Journal:  J Clin Virol       Date:  2016-10-28       Impact factor: 3.168

2.  Short-term natural history of high-risk human papillomavirus infection in mid-adult women sampled monthly.

Authors:  Tsung-chieh Jane Fu; Long Fu Xi; Ayaka Hulbert; James P Hughes; Qinghua Feng; Stephen M Schwartz; Stephen E Hawes; Laura A Koutsky; Rachel L Winer
Journal:  Int J Cancer       Date:  2015-05-29       Impact factor: 7.396

Review 3.  The Use of Copper as an Antimicrobial Agent in Health Care, Including Obstetrics and Gynecology.

Authors:  Linda P Arendsen; Ranee Thakar; Abdul H Sultan
Journal:  Clin Microbiol Rev       Date:  2019-08-14       Impact factor: 26.132

4.  Usability Testing of an HPV Information Website for Parents and Adolescents.

Authors:  Randall Starling; Jessica A Nodulman; Alberta S Kong; Cosette M Wheeler; David B Buller; W Gill Woodall
Journal:  Online J Commun Media Technol       Date:  2015-10

5.  Prevalent high-risk HPV infection and vaginal microbiota in Nigerian women.

Authors:  E O Dareng; B Ma; A O Famooto; S N Adebamowo; R A Offiong; O Olaniyan; P S Dakum; C M Wheeler; D Fadrosh; H Yang; P Gajer; R M Brotman; J Ravel; C A Adebamowo
Journal:  Epidemiol Infect       Date:  2015-06-11       Impact factor: 4.434

6.  Prevalence of human papillomavirus in young Italian women with normal cytology: how should we adapt the national vaccination policy?

Authors:  Donatella Panatto; Daniela Amicizia; Elisabetta Tanzi; Silvia Bianchi; Elena Rosanna Frati; Carla Maria Zotti; Piero Luigi Lai; Angela Bechini; Stefania Rossi; Roberto Gasparini
Journal:  BMC Infect Dis       Date:  2013-12-06       Impact factor: 3.090

7.  Bonafide, type-specific human papillomavirus persistence among HIV-positive pregnant women: predictive value for cytological abnormalities, a longitudinal cohort study.

Authors:  Angela Ri Meyrelles; Juliana D Siqueira; Pâmela P Dos Santos; Cristina B Hofer; Ronir R Luiz; Héctor N Seuánez; Gutemberg Almeida; Marcelo A Soares; Esmeralda A Soares; Elizabeth S Machado
Journal:  Mem Inst Oswaldo Cruz       Date:  2016-02       Impact factor: 2.743

8.  High HPV-51 prevalence in invasive cervical cancers: results of a pre-immunization survey in North Sardinia, Italy.

Authors:  Andrea Piana; Giovanni Sotgiu; Clementina Cocuzza; Rosario Musumeci; Vincenzo Marras; Stefania Pischedda; Silvia Deidda; Elena Muresu; Paolo Castiglia
Journal:  PLoS One       Date:  2013-05-22       Impact factor: 3.240

9.  Persistence or clearance of human papillomavirus infections in women in Ouro Preto, Brazil.

Authors:  P M Miranda; N N T Silva; B C V Pitol; I D C G Silva; J L Lima-Filho; R F Carvalho; R C Stocco; W Beçak; A A Lima
Journal:  Biomed Res Int       Date:  2013-11-05       Impact factor: 3.411

10.  Incidence and duration of type-specific human papillomavirus infection in high-risk HPV-naïve women: results from the control arm of a phase II HPV-16/18 vaccine trial.

Authors:  Agnihotram V Ramanakumar; Paulo Naud; Cecilia M Roteli-Martins; Newton S de Carvalho; Paola C de Borba; Julio C Teixeira; Mark Blatter; Anna-Barbara Moscicki; Diane M Harper; Barbara Romanowski; Stephen K Tyring; Brian Ramjattan; Anne Schuind; Gary Dubin; Eduardo L Franco
Journal:  BMJ Open       Date:  2016-08-26       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.